What specific challenges have been encountered with traditional MES since their launch, and how do these issues impact operational efficiency?
How does a system-agnostic approach enhance the adaptability and scalability of next-generation MES for gene companies?
What key features should be prioritized in next-generation MES to ensure alignment with the operational goals of gene companies and improve overall productivity?